Preferred drug for adult patients who are not eligible for hematopoietic stem cell transplantation and who suffer from: myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia..
FORMULATIONS:
Each glass vial contains 100 mg of azacitidine in a formulation as sterile lyophilized powder for reconstitution. After reconstitution, the resulting suspension contains 25 mg/ml of azacitidine.
The material on this website is oriented to healthcare professionals only. It aims to provide information on how to use these medications efficiently, and to spread the knowledge of these products. This information does not substitute medical diagnosis, advice and indication. Biosidus recommends asking a doctor first.
The texts referring to our prescription drugs abide by the National Administration of Drugs, Foods and Medical Devices (ANMAT) in the Argentine Republic approved guidelines.